Researchers have developed a synthetic biological strategy to enable Clostridium sporogenes to thrive in the low oxygen ...

Dyadic Applied BioSolutions ('Dyadic”, 'we”, 'us”, 'our”, or the 'Company”) (NASDAQ: DYAI), a global biotechnology company ...

Gene therapy that can cross the blood–brain barrier represents a non-invasive way to map gene expression in the brains of ...

Franzen wants to move DuPont from the materials sector, where it is considered a specialty chemicals company, to somewhere in ...

Inside every cell, thousands of molecular signals collide, overlap, and compensate, obscuring the true drivers of gene expression.

Neuroscientists propose a new theory of brain development where cells organize based on lineage rather than long-range signals.

Researchers develop synthetic markers that cross the blood-brain barrier, allowing for noninvasive monitoring of the living brain via blood tests.

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, hemophilia and, recently, Huntington's disease, a fatal neurological ...

"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.

Gene therapy has been successfully used to treat a number of diseases, including immune deficiencies, hereditary blindness, ...

The field of cancer genetics and oncogenomics is undergoing a transformative shift as multi-omics approaches become central to understanding the complex ...

Older adults with exceptional memories continue to grow new brain cells. A recent study published in the journal Nature shows ...